TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 SEK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
0
|
0
|
845 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-192
|
-330
|
100 |
| EBITDA |
-192
|
-330
|
100 |
| Total assets |
151
|
253
|
625 |
| Current assets |
151
|
253
|
625 |
| Current liabilities |
69
|
79
|
121 |
| Equity capital |
80
|
172
|
502 |
| - share capital |
150
|
150
|
150 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
53.0%
|
68.0%
|
80.3% |
| Turnover per employee |
0
|
0
|
845 |
| Profit as a percentage of turnover | 11.8% | ||
| Return on assets (ROA) |
-127.2%
|
-130.4%
|
16.0% |
| Current ratio |
218.8%
|
320.3%
|
516.5% |
| Return on equity (ROE) |
-240.0%
|
-191.9%
|
19.9% |
| Change turnover |
0
|
-845
|
-125 |
| Change turnover % |
-100%
|
-13% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.